Hatad, Resty Joy O.

HRN: 21/37/26  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2023
CEFUROXIME 500MG (TAB)
11/14/2023
11/20/2023
PO
500
BID
Thinly MSAF
Waiting Final Action 
11/14/2023
METRONIDAZOLE 500MG (TAB)
11/14/2023
11/20/2023
ORAL
500mg
TID
Thinly Msaf
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: